Learn More
BACKGROUND Surgical resection with curative intent for giant cell tumor of bone (GCTB) may be associated with severe morbidity. This interim analysis evaluated reduction in surgical invasiveness after denosumab treatment in patients with resectable GCTB. METHODS Patients with primary or recurrent GCTB, for whom the initially planned surgery was associated(More)
  • 1